About MagForce
MagForce is a company based in Berlin (Germany) founded in 1997. MagForce offers products and services including NanoTherm Therapy System, NanoActivator, NanoTherm AS1, and NanoPlan. MagForce operates in a competitive market with competitors including ElmediX, Sensius, Siva Therapeutics, NeoTherma Oncology and MagHeals, among others.
- Headquarter Berlin, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Magforce Nt Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$15 M (USD), Post-IPO
Aug 08, 2014
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MagForce
MagForce offers a comprehensive portfolio of products and services, including NanoTherm Therapy System, NanoActivator, NanoTherm AS1, and NanoPlan.
System for treating glioblastoma using magnetic nanoparticles to heat tumors.
Magnetic field generator for nanoparticle activation in therapy.
Magnetic ferrofluid for targeted cancer cell destruction.
Tool for optimizing nanoparticle therapy results.
Funding Insights of MagForce
Investors in MagForce
MagForce has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Mithril.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are made in the UK and US.
|
Locked | Locked | Locked |
Investor details for MagForce
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MagForce
Investment portfolio details for MagForce
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MagForce
Detailed financials for MagForce
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Magforce Comparisons
Peer comparison for MagForce
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MagForce
MagForce operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ElmediX, Sensius, Siva Therapeutics, NeoTherma Oncology and MagHeals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of the device for treating pancreatic cancer
|
|
| Locked | Locked | Locked |
Developer of a hyperthermia system for cancer treatment. This system uses thermotherapy, a controlled heating process, to target tumors while preserving surrounding healthy tissue. The technology is designed to be integrated with existing radiotherapy workflows, offering improved clinical outcomes and enhanced quality of life for patients. The system is currently in development, with prototypes undergoing clinical trials. Future applications are planned for various cancer types.
|
|
| Locked | Locked | Locked |
Gold nanoparticle hyperthermia technology for cancer therapy is developed.
|
|
| Locked | Locked | Locked |
Deep solid tumors are treated with radio frequency thermal therapy.
|
|
| Locked | Locked | Locked |
Magnetic hyperthermia devices for non-invasive cancer treatment are provided.
|
Detailed competitors of MagForce
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Magforce
Complete news archive for MagForce
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MagForce
MagForce was founded in 1997 and raised its 1st funding round 17 years after it was founded.
MagForce is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Ben Lipps is the current CEO of MagForce.
Founded in 1997 in Berlin, Germany, medical devices focused on oncology are developed by the company. Magnetic hyperthermia technology is employed to treat solid tumors locally. NanoTherm, a liquid responsive to magnetic fields, is offered for therapy application. NanoPlan is utilized for planning via the bioheat transfer equation, while NanoActivator enables treatment of tumors across body areas. Operations center on innovative cancer solutions in the healthcare sector.
MagForce's top competitors include Sensius, MagHeals and Siva Therapeutics.
MagForce offers NanoTherm Therapy System, NanoActivator, NanoTherm AS1, and NanoPlan.
MagForce has 1 investor. Key investors include Mithril.